prazosin hydrochloride

Generic: prazosin hydrochloride

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prazosin hydrochloride
Generic Name prazosin hydrochloride
Labeler teva pharmaceuticals usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

prazosin hydrochloride 5 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-4069
Product ID 0093-4069_b9dbf961-8602-4533-90ad-8e5cf16e6649
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA071745
Listing Expiration 2026-12-31
Marketing Start 2007-01-18

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00934069
Hyphenated Format 0093-4069

Supplemental Identifiers

RxCUI
198141 312593 312594
UPC
0300934068016 0300934069013 0300934067019
UNII
X0Z7454B90

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prazosin hydrochloride (source: ndc)
Generic Name prazosin hydrochloride (source: ndc)
Application Number ANDA071745 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (0093-4069-01)
  • 500 CAPSULE in 1 BOTTLE (0093-4069-05)
  • 250 CAPSULE in 1 BOTTLE (0093-4069-52)
source: ndc

Packages (3)

Ingredients (1)

prazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b9dbf961-8602-4533-90ad-8e5cf16e6649", "openfda": {"upc": ["0300934068016", "0300934069013", "0300934067019"], "unii": ["X0Z7454B90"], "rxcui": ["198141", "312593", "312594"], "spl_set_id": ["7293cef3-ef9e-40dc-9995-875ef047f693"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0093-4069-01)", "package_ndc": "0093-4069-01", "marketing_start_date": "20070222"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (0093-4069-05)", "package_ndc": "0093-4069-05", "marketing_start_date": "20070118"}, {"sample": false, "description": "250 CAPSULE in 1 BOTTLE (0093-4069-52)", "package_ndc": "0093-4069-52", "marketing_start_date": "20070222"}], "brand_name": "Prazosin Hydrochloride", "product_id": "0093-4069_b9dbf961-8602-4533-90ad-8e5cf16e6649", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "0093-4069", "generic_name": "Prazosin Hydrochloride", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Prazosin Hydrochloride", "active_ingredients": [{"name": "PRAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA071745", "marketing_category": "ANDA", "marketing_start_date": "20070118", "listing_expiration_date": "20261231"}